These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3521279)

  • 1. Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid.
    Lachant NA; Tanaka KR
    Am J Med Sci; 1986 Jul; 292(1):3-10. PubMed ID: 3521279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired antioxidant defense in hemoglobin E-containing erythrocytes: a mechanism protective against malaria?
    Lachant NA; Tanaka KR
    Am J Hematol; 1987 Nov; 26(3):211-9. PubMed ID: 3674003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative process in erythrocytes of individuals with hemoglobin S.
    Chaves MA; Leonart MS; do Nascimento AJ
    Hematology; 2008 Jun; 13(3):187-92. PubMed ID: 18702879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired pentose phosphate shunt function in sickle cell disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation.
    Lachant NA; Davidson WD; Tanaka KR
    Am J Hematol; 1983 Aug; 15(1):1-13. PubMed ID: 6881134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythrocyte protective synergism of ascorbic acid and alpha-mercaptopropionylglycine].
    Germanò D; Abbate C; Granata A
    Minerva Med; 1979 Sep; 70(38):2615-9. PubMed ID: 481785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by ascorbate against acetylphenylhydrazine-induced Heinz body formation in glucose-6-phosphate dehydrogenase deficient erythrocytes.
    Winterbourn CC
    Br J Haematol; 1979 Feb; 41(2):245-22. PubMed ID: 427033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell membranes and oxidative damage.
    Rice-Evans C; Omorphos SC; Baysal E
    Biochem J; 1986 Jul; 237(1):265-9. PubMed ID: 3800879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell vitamin E and oxidative damage: a dual role of reducing agents.
    Wang J; Huang CJ; Chow CK
    Free Radic Res; 1996 Apr; 24(4):291-8. PubMed ID: 8731013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of erythrocytes to oxidant stress in uremia.
    Smith CL; Berkseth RO
    Am J Nephrol; 1990; 10(1):61-8. PubMed ID: 2188507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant vitamins C and E supplementation increases markers of haemolysis in sickle cell anaemia patients: a randomized, double-blind, placebo-controlled trial.
    Arruda MM; Mecabo G; Rodrigues CA; Matsuda SS; Rabelo IB; Figueiredo MS
    Br J Haematol; 2013 Mar; 160(5):688-700. PubMed ID: 23278176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vivo.
    Jain SK; Williams DM
    Clin Chim Acta; 1985 Jul; 149(2-3):257-61. PubMed ID: 4028444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant prevention of Heinz body formation and oxidative injury in cats.
    Hill AS; O'Neill S; Rogers QR; Christopher MM
    Am J Vet Res; 2001 Mar; 62(3):370-4. PubMed ID: 11277202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral administration of ascorbate on acetylphenylhydrazine-induced Heinz body formation.
    Williamson D; Winterbourn CC
    Br J Haematol; 1980 Oct; 46(2):319-21. PubMed ID: 7426459
    [No Abstract]   [Full Text] [Related]  

  • 14. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil.
    Muskiet FA; Muskiet FD; Meiborg G; Schermer JG
    Am J Clin Nutr; 1991 Oct; 54(4):736-44. PubMed ID: 1716847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the hematocrit on the formation of Heinz bodies within the red cells (author's transl)].
    Maïer M; Josso F
    Ann Biol Clin (Paris); 1978; 36(4):359-61. PubMed ID: 736319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the nicotinamide adenine dinucleotide redox potential and the 2,3-diphosphoglycerate content in the erythrocyte in sickle cell disease.
    Lachant NA; Zerez CR; Tanaka KR
    Br J Haematol; 1989 Jun; 72(2):265-71. PubMed ID: 2757969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte membrane vacuole formation in hereditary spherocytosis.
    Schrier SL; Ben-Bassat I; Bensch K; Seeger M; Junga I
    Br J Haematol; 1974 Jan; 26(1):59-69. PubMed ID: 4368693
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of vitamins C and E on oxidative processes in human erythrocytes.
    Claro LM; Leonart MS; Comar SR; do Nascimento AJ
    Cell Biochem Funct; 2006; 24(6):531-5. PubMed ID: 16130181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
    Embury SH; Clark MR; Monroy G; Mohandas N
    J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red-cell catalase and the production of methaemoglobin, Heinz bodies and changes in osmotic fragility due to drugs.
    Tudhope GR; Leece SP
    Acta Haematol; 1971; 45(5):290-302. PubMed ID: 5000041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.